Cleveland Clinic Awarded $7.2M NIH Grant for to Study MRI-Based Biomarker in Multiple Sclerosis

What You Should Know:

– Cleveland Clinic-led research team has been awarded a $7.2M grant from the National Institutes of Health (NIH) to support a multi-center study to study CVS, an MRI-based biomarker identified in multiple sclerosis associated white matter lesion.

– The prospective study, referred to as CAVS-MS, will enroll 400 patients with typical or atypical presentations of MS at 11 participating centers in North America, with Cleveland Clinic serving as the coordinating center.

The National Institutes of Health (NIH) has awarded $7.2 million to a Cleveland Clinic-led research team to improve accuracy of multiple sclerosis (MS) diagnoses

Leave a Reply